Search results
Moderna, Inc. (NASDAQ:MRNA) Expected to Earn Q3 2025 Earnings of $1.30 Per Share
ETF DAILY NEWS· 24 hours agoWilliam Blair analyst M. Minter now anticipates that the company will earn $1.30 per share for the quarter, up from their prior estimate of $1.25. William Blair has a “Market Perform” rating ...
Why Moderna Stock Blasted 13% Higher Today
Motley Fool via Yahoo Finance· 4 days agoNormally, investors wouldn't reward such declines and steep shortfalls. But the market was braced for a notably worse showing. On average, analysts...
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 12 hours agoToday, Moderna Inc (MRNA, Financial) experienced a stock price decline of 3.43%, yet it has seen a significant three-month gain of 28.21%. With a current ...
Moderna Stock Takes Minimal Hit After New COVID Vaccine Topped Projected Estimates
Black Enterprise· 4 days agoModerna announced an increase in stock price after their COVID vaccine exceeded sales estimates for...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 4 days agoModerna stock broke out for the first time in over a year on May 2 after the biotech company notched...
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 11 hours agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 4 days agoModerna stock broke out for the first time in a year on Thursday after beating Wall Street's...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 5 days agoModerna stock soared on Thursday after its first-quarter earnings report sailed past Wall Street’s...
Moderna's Options Frenzy: What You Need to Know - Moderna (NASDAQ:MRNA)
Benzinga· 13 hours agoModerna, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance Present Market Standing of
Moderna (MRNA) Reports Q1 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 5 days agoModerna (MRNA) delivered earnings and revenue surprises of 14.48% and 33.88%, respectively, for the...